Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alison Dumont"'
Autor:
Margot Lavy, Vanessa Gauttier, Alison Dumont, Florian Chocteau, Sophie Deshayes, Judith Fresquet, Virginie Dehame, Isabelle Girault, Charlène Trilleaud, Stéphanie Neyton, Caroline Mary, Philippe Juin, Nicolas Poirier, Sophie Barillé-Nion, Christophe Blanquart
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionTumor Associated Macrophages (TAM) are a major component of the tumor environment and their accumulation often correlates with poor prognosis by contributing to local inflammation, inhibition of anti-tumor immune response and resistance t
Externí odkaz:
https://doaj.org/article/d99530eb600e4897901d77bbb348a2e0
Autor:
Steven Lohard, Nathalie Bourgeois, Laurent Maillet, Fabien Gautier, Aurélie Fétiveau, Hamza Lasla, Frédérique Nguyen, Céline Vuillier, Alison Dumont, Agnès Moreau-Aubry, Morgane Frapin, Laurent David, Delphine Loussouarn, Olivier Kerdraon, Mario Campone, Pascal Jézéquel, Philippe P. Juin, Sophie Barillé-Nion
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-16 (2020)
Antimitotic compounds, such as paclitaxel, induce cell death in cycling cancer cells only. Here, the authors show that paclitaxel-targeted breast cancer cells prime neighboring cells to apoptosis through a STING-mediated paracrine signaling pathway.
Externí odkaz:
https://doaj.org/article/0aa8ad60806d444b913612a87eb4037b
Publikováno v:
Journal of Cellular Signaling
Journal of Cellular Signaling, 2020, 1 (4), pp.127
Journal of Cellular Signaling, Scientific Archives, 2020, 1 (4), pp.127
Journal of Cellular Signaling, 2020, 1 (4), pp.127
Journal of Cellular Signaling, Scientific Archives, 2020, 1 (4), pp.127
International audience; NOXA is a critical mediator of stress responses to anticancer drugs. This BH3-only protein sets the apoptotic threshold in cancer cells in response to chemotherapies by counteracting the prosurvival BCL-2 family protein MCL-1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a14d918c6ef2ee551a847b396de159f
https://www.hal.inserm.fr/inserm-03171678
https://www.hal.inserm.fr/inserm-03171678